These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 22014068)

  • 1. S(+)amphetamine induces a persistent leak in the human dopamine transporter: molecular stent hypothesis.
    Rodriguez-Menchaca AA; Solis E; Cameron K; De Felice LJ
    Br J Pharmacol; 2012 Apr; 165(8):2749-57. PubMed ID: 22014068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural analysis of dopamine- and amphetamine-induced depolarization currents in the human dopamine transporter.
    Tang QY; Kolanos R; De Felice LJ; Glennon RA
    ACS Chem Neurosci; 2015 Apr; 6(4):551-8. PubMed ID: 25594379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amphetamine regulation of dopamine transport. Combined measurements of transporter currents and transporter imaging support the endocytosis of an active carrier.
    Kahlig KM; Javitch JA; Galli A
    J Biol Chem; 2004 Mar; 279(10):8966-75. PubMed ID: 14699142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amphetamine-induced dopamine efflux. A voltage-sensitive and intracellular Na+-dependent mechanism.
    Khoshbouei H; Wang H; Lechleiter JD; Javitch JA; Galli A
    J Biol Chem; 2003 Apr; 278(14):12070-7. PubMed ID: 12556446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amphetamine activates calcium channels through dopamine transporter-mediated depolarization.
    Cameron KN; Solis E; Ruchala I; De Felice LJ; Eltit JM
    Cell Calcium; 2015 Nov; 58(5):457-66. PubMed ID: 26162812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Syntaxin 1A interaction with the dopamine transporter promotes amphetamine-induced dopamine efflux.
    Binda F; Dipace C; Bowton E; Robertson SD; Lute BJ; Fog JU; Zhang M; Sen N; Colbran RJ; Gnegy ME; Gether U; Javitch JA; Erreger K; Galli A
    Mol Pharmacol; 2008 Oct; 74(4):1101-8. PubMed ID: 18617632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of dopamine transporter trafficking by intracellular amphetamine.
    Kahlig KM; Lute BJ; Wei Y; Loland CJ; Gether U; Javitch JA; Galli A
    Mol Pharmacol; 2006 Aug; 70(2):542-8. PubMed ID: 16684900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple ionic conductances of the human dopamine transporter: the actions of dopamine and psychostimulants.
    Sonders MS; Zhu SJ; Zahniser NR; Kavanaugh MP; Amara SG
    J Neurosci; 1997 Feb; 17(3):960-74. PubMed ID: 8994051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bath salts components mephedrone and methylenedioxypyrovalerone (MDPV) act synergistically at the human dopamine transporter.
    Cameron KN; Kolanos R; Solis E; Glennon RA; De Felice LJ
    Br J Pharmacol; 2013 Apr; 168(7):1750-7. PubMed ID: 23170765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amphetamine induces dopamine efflux through a dopamine transporter channel.
    Kahlig KM; Binda F; Khoshbouei H; Blakely RD; McMahon DG; Javitch JA; Galli A
    Proc Natl Acad Sci U S A; 2005 Mar; 102(9):3495-500. PubMed ID: 15728379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amphetamine-induced reverse transport of dopamine does not require cytosolic Ca
    Støier JF; Konomi-Pilkati A; Apuschkin M; Herborg F; Gether U
    J Biol Chem; 2023 Aug; 299(8):105063. PubMed ID: 37468107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Currents in response to rapid concentration jumps of amphetamine uncover novel aspects of human dopamine transporter function.
    Erreger K; Grewer C; Javitch JA; Galli A
    J Neurosci; 2008 Jan; 28(4):976-89. PubMed ID: 18216205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amphetamine-induced loss of human dopamine transporter activity: an internalization-dependent and cocaine-sensitive mechanism.
    Saunders C; Ferrer JV; Shi L; Chen J; Merrill G; Lamb ME; Leeb-Lundberg LM; Carvelli L; Javitch JA; Galli A
    Proc Natl Acad Sci U S A; 2000 Jun; 97(12):6850-5. PubMed ID: 10823899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter.
    Jones SR; Gainetdinov RR; Wightman RM; Caron MG
    J Neurosci; 1998 Mar; 18(6):1979-86. PubMed ID: 9482784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amphetamine and methamphetamine differentially affect dopamine transporters in vitro and in vivo.
    Goodwin JS; Larson GA; Swant J; Sen N; Javitch JA; Zahniser NR; De Felice LJ; Khoshbouei H
    J Biol Chem; 2009 Jan; 284(5):2978-2989. PubMed ID: 19047053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SLC6A3 coding variant Ala559Val found in two autism probands alters dopamine transporter function and trafficking.
    Bowton E; Saunders C; Reddy IA; Campbell NG; Hamilton PJ; Henry LK; Coon H; Sakrikar D; Veenstra-VanderWeele JM; Blakely RD; Sutcliffe J; Matthies HJ; Erreger K; Galli A
    Transl Psychiatry; 2014 Oct; 4(10):e464. PubMed ID: 25313507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Akt is essential for insulin modulation of amphetamine-induced human dopamine transporter cell-surface redistribution.
    Garcia BG; Wei Y; Moron JA; Lin RZ; Javitch JA; Galli A
    Mol Pharmacol; 2005 Jul; 68(1):102-9. PubMed ID: 15795321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. G protein-coupled receptor signaling in VTA dopaminergic neurons bidirectionally regulates the acute locomotor response to amphetamine but does not affect behavioral sensitization.
    Runegaard AH; Dencker D; Wörtwein G; Gether U
    Neuropharmacology; 2019 Dec; 161():107663. PubMed ID: 31173760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attenuation of estradiol on the reduction of striatal dopamine by amphetamine in ovariectomized rats.
    Yu PL; Wu CI; Lee TS; Pan WH; Wang PS; Wang SW
    J Cell Biochem; 2009 Dec; 108(6):1318-24. PubMed ID: 19830701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine transporter activity mediates amphetamine-induced inhibition of Akt through a Ca2+/calmodulin-dependent kinase II-dependent mechanism.
    Wei Y; Williams JM; Dipace C; Sung U; Javitch JA; Galli A; Saunders C
    Mol Pharmacol; 2007 Mar; 71(3):835-42. PubMed ID: 17164407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.